Anti-IGF-1R monoclonal antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-IGF-1R monoclonal antibody, covering 2025-12-04 to 2025-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Safety and Efficacy Evaluation of Anti IGF-1R Monoclonal Antibody Combined With Anti-PD-1 Monoclonal Antibody in Treatment in Patients With Metastatic Castration-Resistant Prostate Cancer [EARLY_Phase 1]